118 related articles for article (PubMed ID: 32372175)
1. Signification of forkhead box A1 (FOXA1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract][Full Text] [Related]
2. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
3. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
[TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan L; Yang Z; Jiang X; Zhang J; Guo X
Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
[TBL] [Abstract][Full Text] [Related]
6. Revising the embryonic origin of thyroid C cells in mice and humans.
Johansson E; Andersson L; Örnros J; Carlsson T; Ingeson-Carlsson C; Liang S; Dahlberg J; Jansson S; Parrillo L; Zoppoli P; Barila GO; Altschuler DL; Padula D; Lickert H; Fagman H; Nilsson M
Development; 2015 Oct; 142(20):3519-28. PubMed ID: 26395490
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
Hirsch MS; Faquin WC; Krane JF
Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
[TBL] [Abstract][Full Text] [Related]
8. GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
Haber RS; Weiser KR; Pritsker A; Reder I; Burstein DE
Thyroid; 1997 Jun; 7(3):363-7. PubMed ID: 9226204
[TBL] [Abstract][Full Text] [Related]
9. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
Bishop JA; Sharma R; Westra WH
Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
[TBL] [Abstract][Full Text] [Related]
10. Presence of endothelin-1 in the normal and pathological human thyroid.
Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
[TBL] [Abstract][Full Text] [Related]
11. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
12. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
14. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
Unger P; Ewart M; Wang BY; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2003 Aug; 34(8):764-9. PubMed ID: 14506636
[TBL] [Abstract][Full Text] [Related]
15. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
16. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
17. Proteomics for the diagnosis of thyroid lesions: preliminary report.
Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
[TBL] [Abstract][Full Text] [Related]
18. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
Kurczyk A; Gawin M; Chekan M; Wilk A; Łakomiec K; Mrukwa G; Frątczak K; Polanska J; Fujarewicz K; Pietrowska M; Widlak P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878024
[TBL] [Abstract][Full Text] [Related]
19. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
20. Fine-Needle Aspiration with Immunohistochemistry Using a Modified Scrape Cell Block Technique for the Diagnosis of Thyroid and Parathyroid Nodules.
Wuertz FG; Kresnik E; Malle P; Hyden M; Lind P; Rogatsch H; Gallowitsch HJ
Acta Cytol; 2016; 60(2):118-30. PubMed ID: 27231232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]